Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026
-
The Beauty Health Company reported fourth quarter and full year 2025 financial results reflecting continued improvement in margins and profitability.
-
Longeveron to report 2025 full year financial results and provide a business update on March 17, 2026 after the U.S. financial markets close.
-
JENA, Germany, March 12, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...
-
TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) today announced its fourth quarter (Q4) and full year results for the period ended December 31, 2025, along with an update on...
-
Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow
-
DP World reports strong 2025 financial results globally and across the Americas, driven by resilient trade demand and logistics growth.
-
Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
BioNTech erwartet ein Jahr mit zahlreichen wertrelevanten Meilensteinen (Katalysatoren) mit sechs Datenveröffentlichungen aus der späten klinischen Entwicklung, welche Immunmodulatoren,...
-
BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on...